The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection
Open accessAbstract
Previous studies have reached conflicting conclusions regarding the proportion of Merkel cell carcinomas (MCCs) that contain the Merkel cell polyomavirus (MCPyV) and the clinical significance of tumor viral status. To address these controversies, we detected MCPyV large T antigen using immunohistochemistry with two distinct antibodies and MCPyV DNA using quantitative PCR. Tumors were called MCPyV-positive if two or more of these three assays indicated presence of this virus. A total of 53 of 282 (19%) MCC tumors in this cohort were virus-negative using this multimodal system. Immunohistochemistry with the CM2B4 antibody had the best overall performance (sensitivity = 0.882, specificity = 0.943) compared with the multimodal classification. Multivariate analysis including age, sex, and immunosuppression showed that, relative to MCC patients with virus-positive tumors, virus-negative MCC patients had significantly increased risk of disease progression (hazard ratio = 1.77, 95% confidence interval = 1.20–2.62) and death from MCC (hazard ratio = 1.85, 95% confidence interval = 1.19–2.89). We confirm that approximately 20% of MCCs are not driven by MCPyV and that such virus-negative MCCs, which can be quite reliably identified by immunohistochemistry using the CM2B4 antibody alone, represent a more aggressive subtype that warrants closer clinical follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma
Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603702 · Cited by 1,258
Self-citationUse of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions
Longo, M. C., Berninger, M. S., & Hartley, J. L. (1990) · Gene · doi:10.1016/0378-1119(90)90145-h · Cited by 960
Lemos, B. D., Storer, B. E., Iyer, J. G., Phillips, J. L., Bichakjian, C. K., Fang, L. C., Johnson, T. M., Liegeois-Kwon, N. J., Otley, C. C., Paulson, K. G., et al. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.056 · Cited by 559
Self-citationMerkel cell carcinoma and HIV infection
Engels, E. A., Frisch, M., Goedert, J. J., Biggar, R. J., & Miller, R. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07668-7 · Cited by 550
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Houben, R., Shuda, M., Weinkam, R., Schrama, D., Feng, H., Chang, Y., Moore, P. S., & Becker, J. C. (2010) · Journal of Virology · doi:10.1128/jvi.02400-09 · Cited by 457
Goh, G., Walradt, T., Markarov, V., Blom, A., Riaz, N., Doumani, R., Stafstrom, K., Moshiri, A., Yelistratova, L., Levinsohn, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6494 · Cited by 387
Self-citationShuda, M., Arora, R., Kwun, H. J., Feng, H., Sarid, R., Fernández‐Figueras, M., Tolstov, Y., Gjoerup, O., Mansukhani, M. M., Swerdlow, S. H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24510 · Cited by 373
Kassem, A., Schöpflin, A., Diaz, C., Weyers, W., Stickeler, E., Werner, M., & zur Hausen, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0949 · Cited by 369
A cornucopia of human polyomaviruses
DeCaprio, J. A., & Garcea, R. L. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2992 · Cited by 363
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Harms, P. W., Vats, P., Verhaegen, M. E., Robinson, D. R., Wu, Y.-M., Dhanasekaran, S. M., Palanisamy, N., Siddiqui, J., Cao, X., Su, F., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0702 · Cited by 345
Paulson, K. G., Warcola, A. H., Feng, Q., Kiviat, N. B., Leonard, J. H., & Nghiem, P. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.229 · Cited by 335
Self-citationClinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma
Sihto, H. J., Kukko, H., Koljonen, V., Sankila, R. J., Böhling, T., & Joensuu, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp139 · Cited by 305
Paulson, K. G., Carter, J. J., Johnson, L. G., Cahill, K. W., Iyer, J. G., Schrama, D., Becker, J. C., Madeleine, M. M., Nghiem, P., & Galloway, D. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2128 · Cited by 240
Self-citationImproved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
Rodig, S. J., Cheng, J., Wardzala, J., DoRosario, A., Scanlon, J. J., Laga, A. C., Martinez-Fernandez, A., Barletta, J. A., Bellizzi, A. M., Sadasivam, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64116 · Cited by 228
Dramatic Increase in the Incidence and Mortality from Merkel Cell Carcinoma in the United States
Fitzgerald, T. L., Dennis, S., Kachare, S. D., Vohra, N. A., Wong, J. H., & Zervos, E. E. (2015) · The American Surgeon™ · doi:10.1177/000313481508100819 · Cited by 220
Merkel Cell Carcinoma: More Deaths but Still No Pathway to Blame
Lemos, B., & Nghiem, P. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700925 · Cited by 213
Self-citationMerkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma
Schrama, D., Peitsch, W. K., Zapatka, M., Kneitz, H., Houben, R., Eib, S., Haferkamp, S., Moore, P. S., Shuda, M., Thompson, J. F., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.115 · Cited by 176
Paulson, K. G., Lemos, B. D., Feng, B., Jaimes, N., Fernández‐Peñas, P., Bi, X., Maher, E. A., Cohen, L., Leonard, J. H., Granter, S. R., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.365 · Cited by 140
Self-citationHarms, P. W., Patel, R. M., Verhaegen, M. E., Giordano, T. J., Nash, K. T., Johnson, C. N., Daignault, S. D., Thomas, D. G., Gudjonsson, J. E., Elder, J. T., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.445 · Cited by 134
Activation of PI3K Signaling in Merkel Cell Carcinoma
Nardi, V., Song, Y., Santamaria‐Barria, J. A., Cosper, A. K., Lam, Q., Faber, A. C., Boland, G. M., Yeap, B. Y., Bergethon, K. E., Scialabba, V. L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2308 · Cited by 121
Prevalence of MCPyV in Merkel cell carcinoma and non‐MCC tumors
Andres, C., Belloni, B., Puchta, U., Sander, C. A., & Flaig, M. J. (2009) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01352.x · Cited by 120
Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
Foulongne, V., Kluger, N., Dereure, O., Brieu, N., Guillot, B., & Segondy, M. (2008) · Emerging infectious diseases · doi:10.3201/eid1409.080651 · Cited by 113
Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma
Katano, H., 伊東, 秀., Suzuki, Y., Nakamura, T., Sato, Y., Tsuji, T., Matsuo, K., Nakagawa, H., & Sata, T. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21608 · Cited by 109
Leroux-Kozal, V., Lévêque, N., Brodard, V., Lesage, C., Dudez, O., Makeieff, M., Kanagaratnam, L., & Diébold, M.-D. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.12.001 · Cited by 82
Cited by
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
Rindi, G., Mete, O., Uccella, S., Basturk, O., La Rosa, S., Brosens, L. A. A., Ezzat, S., de Herder, W. W., Klimstra, D. S., Papotti, M., et al. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09708-2 · Cited by 1,036
Becker, J. C., Stang, A., DeCaprio, J. A., Cerroni, L., Lebbé, C., Veness, M., & Nghiem, P. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.77 · Cited by 645
Self-citationNghiem, P., Bhatia, S., Lipson, E. J., Sharfman, W. H., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01896 · Cited by 396
Self-citationThe biology and treatment of Merkel cell carcinoma: current understanding and research priorities
on behalf of the International Workshop on Merkel Cell Carcinoma Research (IWMCC) Working Group, Harms, P. W., Harms, K. L., Moore, P. S., DeCaprio, J. A., Nghiem, P., Wong, M. K. K., & Brownell, I. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0103-2 · Cited by 316
Self-citationNeoadjuvant nivolumab for patients with resectable merkel cell carcinoma in the CheckMate 358 trial
Topalian, S. L., Bhatia, S., Amin, A., Kudchadkar, R. R., Sharfman, W. H., Lebbé, C., Delord, J.-P., Dunn, L. A., Shinohara, M. M., Kulikauskas, R., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00201 · Cited by 280
Self-citation
Metadata
- Authors
- Moshiri, A. S., Doumani, R., Yelistratova, L., Blom, A., Lachance, K., Shinohara, M. M., Delaney, M., Chang, O., McArdle, S., Thomas, H., Asgari, M. M., Huang, M.-L., Schwartz, S. M., & Nghiem, P.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 137
- Issue
- 4
- Pages
- 819-827
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2547701444
- Cited by
- 281
- References
- 26
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.